Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer
Clinical trial NCT00193024 · TERMINATED
Trial details
- NCT number
- NCT00193024
- Sponsor
- SCRI Development Innovations, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-09-01
- Primary completion
- 2003-10-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.